Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Sep 2, 2024
Date Accepted: Jul 28, 2025

The final, peer-reviewed published version of this preprint can be found here:

Digital Health Tool for Preventing Blindness From Diabetic Retinopathy: Protocol for a Qualitative Study

Frimpong A, Granados A, Chang T, Fu J, Applebaum SS, Kaur M, Adepoju B, Moore SG, Hari Krishnan V, Levi A, McCall T, Nwanyanwu KH

Digital Health Tool for Preventing Blindness From Diabetic Retinopathy: Protocol for a Qualitative Study

JMIR Res Protoc 2025;14:e65894

DOI: 10.2196/65894

PMID: 41223405

PMCID: 12658399

Digital Health Tool for Preventing Blindness from Diabetic Retinopathy: Protocol for a Qualitative Study

  • Akua Frimpong; 
  • Alvaro Granados; 
  • Thomas Chang; 
  • Julia Fu; 
  • Serina S Applebaum; 
  • Mahima Kaur; 
  • Bolatito Adepoju; 
  • Shannan G Moore; 
  • Vignesh Hari Krishnan; 
  • Amanda Levi; 
  • Terika McCall; 
  • Kristen Harris Nwanyanwu

ABSTRACT

Background:

Diabetic retinopathy (DR), a leading cause of preventable blindness among working-aged adults, leads to worse health outcomes among Black, Latine, and low-income individuals in comparison to other ethnic, racial, and socioeconomic groups in the United States.

Objective:

We aim to engage community members directly to identify barriers and facilitators of DR screening and co-design a digital health tool that is accessible, user-friendly, and community responsive.

Methods:

We conducted focus groups with individuals from the Greater New Haven, Connecticut area age 18 years and older and diagnosed with diabetes to (1) conduct a comprehensive disease-management needs assessment and (2) inform development of a community-responsive digital health tool to optimize DR education and to increase access to DR screening in high-risk populations. We transcribed the focus group interviews, used rapid qualitative analysis to generate themes, and completed affinity mapping to identify content and features for a digital health tool for preventing blindness from diabetic retinopathy.

Results:

As of March 2025, we recruited and interviewed 19 individuals (68% female, 47% Black, 26% Hispanic, 11% indigenous) for 4 focus groups. Over 80% had access to smart devices. Participants self-reported A1c mean (sd) of 6.77 (1.93). Almost half (48%) of participants completed some college. Frequently occurring themes (f > 30) obtained from coding contextual interviews were: desired app attributes like customization, mental impact, informal support, diabetes education, barriers, dietary guidance, and notifications. We created high fidelity wireframes incorporating key features. Next, we will iteratively design a prototype with community feedback.

Conclusions:

We anticipate that the study will characterize the experiences of people living with a chronic disease such as diabetes. Using a community led approach, we will analyze the information which will generate insights regarding the key benefits that are most important for the creation of a digital health tool.


 Citation

Please cite as:

Frimpong A, Granados A, Chang T, Fu J, Applebaum SS, Kaur M, Adepoju B, Moore SG, Hari Krishnan V, Levi A, McCall T, Nwanyanwu KH

Digital Health Tool for Preventing Blindness From Diabetic Retinopathy: Protocol for a Qualitative Study

JMIR Res Protoc 2025;14:e65894

DOI: 10.2196/65894

PMID: 41223405

PMCID: 12658399

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.